Connection
David Simpson to Oligopeptides
This is a "connection" page, showing publications David Simpson has written about Oligopeptides.
|
|
Connection Strength |
|
 |
|
 |
|
0.246 |
|
|
|
-
Bennett R, Chan H, Henderson R, Merriman E, Hanna M, Elinder-Camburn A, Simpson D. The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience. Leuk Lymphoma. 2022 07; 63(7):1738-1741.
Score: 0.176
-
Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 Jan 02; 23(1):83-7.
Score: 0.071